Nanoparticle-Mediated Multiple Modulation of Bone Microenvironment To Tackle Osteoarthritis

Area of Science:

• Biomaterials Science
• Nanomedicine
• Immunomodulation

Background:

• Osteoarthritis (OA) treatment requires nanomedicines that scavenge reactive oxygen species (ROS) and inhibit inflammatory cytokines while promoting osteogenesis.
• Current treatments face challenges in addressing the complex inflammatory and degenerative processes in OA.

Purpose of the Study:

• To design and evaluate a ROS-responsive nanomedicine formulation for effective osteoarthritis treatment.
• To investigate the collaborative functions of ROS scavenging, anti-inflammation, and osteogenesis promotion by the developed nanomedicine.

Main Methods:

• Fibronectin (FN)-coated polymer nanoparticles (NPs) loaded with azabisdimethylphoaphonate-terminated phosphorus dendrimers (G4-TBP) were synthesized (G4-TBP NPs-FN).
• The nanomedicine's uptake by macrophages via FN-mediated targeting and its dissociation in an oxidative inflammatory microenvironment were assessed.
• In vivo studies in an OA model were conducted to evaluate therapeutic efficacy, including synovitis inhibition, cartilage protection, and promotion of osteogenic differentiation.

Main Results:

• The G4-TBP NPs-FN (268 nm) demonstrated stability under physiological conditions and specific macrophage uptake.
• The formulation exhibited integrated functions: ROS scavenging, hypoxia attenuation, and M2 macrophage polarization, protecting macrophages from apoptosis.
• In vivo, G4-TBP NPs-FN effectively treated OA, reducing joint pathology and promoting osteogenic differentiation for bone repair.

Conclusions:

• The developed nanomedicine formulation effectively addresses multiple pathological aspects of osteoarthritis.
• Combining phosphorus dendrimers and fibronectin offers a promising strategy for immunomodulatory therapy in OA and other inflammatory diseases.